Closed

Provision of imported plasma and recombinant products

Tender ID: 573646


Tender Details

Organisation:
Tender #:
CBP_CON_001  
Status:
Closed
Publish Date:
25 November 2024
Closing Date:
24 January 2025

Tender Description

The National Blood Authority (NBA) invites Tenders for the provision of imported plasma and recombinant products, namely recombinant Factor VIII (rFVIII) and Factor IX (rFIX) products.

The aim of this procurement process is to establish new national supply arrangements for those product types approved and funded under the national blood arrangements, with deeds (including all extension options) expiring on 30 June 2025. These include:

  •  Extended Half Life (EHL)
  • Standard Half Life (SHL)Recombinant Factor VIII (rFVIII) and Recombinant Factor IX (rFIX)

The NBA procures a range of blood products for distribution across the Australian health sector. This is a central and fundamental element of the NBA’s functions under the National Blood Authority Act 2003 and the National Blood Agreement (national blood arrangements).

The NBA’s objective in these procurements is to achieve the first primary policy objective of Australian governments under the national blood arrangements, which is to:

  • provide an adequate, safe, secure and affordable supply of blood products, blood related products and blood related services in Australia

The NBA also seeks to ensure that contract and supply arrangements for blood products support the second primary policy objective under the national blood arrangements, which is to:

  • promote safe, high-quality management and use of blood products, blood related products and blood related services in Australia



Icon
Interested to find more tenders relevant to you and your business? You can try our advanced tender search today.